뒤로
Dri Healthcare Trust(DHTRF) 가격
DHTRF 주가 차트
DHTRF 가격
Dri Healthcare Trust
$11.48
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$11.48
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$11.48
시가
$11.48
일일 범위
$11.48 - $11.48
52주 범위
$7.54 - $13.02
거래량
--
평균 거래량
917
EPS(TTM)
-0.94
배당수익률
--
시가총액
$632.5M
DHTRF란 무엇인가요?
DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.
